fb_script

Early probiotic use could help prevent type 1 diabetes in at-risk children

Giving probiotics to babies in the first few weeks of life may lower their risk of developing type 1 diabetes, a recent study has found.

yogurt

The study, published in JAMA Pediatrics found that children who were given probiotics within the first 27 days of life had a 60% reduction in the risk of developing islet autoimmunity, compared with children who were first given probiotics after 27 days or not at all. Read More

Sanofi and Lexicon Pharmaceuticals partner on new non-insulin therapy for type 1 diabetes

JDRF partner Sanofi and Lexicon Pharmaceuticals have announced a new collaboration to develop and commercialise a new oral drug for the treatment of type 1 diabetes.

Nadav Kidron, CEO of Oramed Pharmaceuticals, poses for a photo in Jerusalem

The drug is called sotagliflozin and is used in conjunction with insulin to help improve blood glucose levels by blocking glucose absorption in the kidneys and the gut.  Read More